Treatment of dementia with lewy bodies
- PMID: 24222315
- PMCID: PMC3913181
- DOI: 10.1007/s11940-013-0261-6
Treatment of dementia with lewy bodies
Abstract
Dementia with Lewy bodies (DLB) is a multisystem disorder with diverse disease expression. A treatment regime restricted to the cognitive aspects of the disease does no favor to patients. Instead, patients should be educated to recognize the symptoms of this multisystem involvement. There are no treatments that slow the progression of disease, but symptomatic treatments can be effective. When thinking about treatment, we find it useful to divide the symptoms and signs into five categories: (a) cognitive features, (b) neuropsychiatric features, (c) motor dysfunction, (d) autonomic dysfunction, and (e) sleep dysfunction. Clinicians, funding bodies and industry are increasingly recognizing the importance of this common and debilitating disease.
References
-
- McKeith I, et al. Dementia with Lewy bodies: Diagnosis and management: Third report of the DLB Consortium. Neurology. 2005;65:1863–1872. - PubMed
-
- McKeith IG, et al. Prospective validation of consensus criteria for the diagnosis of dementia with Lewy bodies. Neurology. 2000;54(5):1050–8. - PubMed
-
- Zaccai J, McCracken C, Brayne C. A systematic review of prevalence and incidence studies of dementia with Lewy bodies. Age Ageing. 2005;34(6):561–6. - PubMed
-
- Boeve B. Noseworthy JW, editor. Diagnosis and Management of NonAlzheimer Dementias. Neurological Therapeutics: Principles and Practice. 2005
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
